Cargando…

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands

Background The impact of age and adjuvant therapy on contralateral breast cancer (CBC) risk and prognostic significance of CBC were evaluated. Patients and Methods In 45,229 surgically treated stage I–IIIA patients diagnosed in the Netherlands between 1989 and 2002 CBC risk was quantified using stan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaapveld, Michael, Visser, Otto, Louwman, W. J., Willemse, Pax H. B., de Vries, Elisabeth G. E., van der Graaf, Winette T. A., Otter, Renée, Coebergh, Jan Willem W., van Leeuwen, Flora E.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2007
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440941/ https://www.ncbi.nlm.nih.gov/pubmed/17687645 http://dx.doi.org/10.1007/s10549-007-9709-2

Ejemplares similares

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
por: Broeks, Annegien, et al.
Publicado: (2007)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
por: Schaapveld, M, et al.
Publicado: (2012)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003)

Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy
por: Davies, Kalatu R, et al.
Publicado: (2015)

Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2018)

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort
por: Akdeniz, Delal, et al.
Publicado: (2022)

Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands
por: Aarts, M J, et al.
Publicado: (2012)

Correction to: Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2018)

Prediction and clinical utility of a contralateral breast cancer risk model
por: Giardiello, Daniele, et al.
Publicado: (2019)

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
por: van Sprundel, T C, et al.
Publicado: (2005)

Only one breast remains at risk of contralateral cancer
por: Peto, R.
Publicado: (1987)

Risk of contralateral breast cancer in Denmark 1943-80.
por: Storm, H. H., et al.
Publicado: (1986)

Patterns of metastasis in women with metachronous contralateral breast cancer
por: Vichapat, V, et al.
Publicado: (2012)

Axillary metastasis from occult breast cancer and synchronous contralateral breast cancer initially suspected to be cancer with contralateral axillary metastasis: a case report
por: Song, Myung Won, et al.
Publicado: (2021)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

MRI evaluation of the contralateral breast in patients with recently diagnosed breast cancer
por: Taneja, Sangeeta, et al.
Publicado: (2012)

Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer
por: Kim, Hakyoung, et al.
Publicado: (2023)

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy
por: Schaapveld, M, et al.
Publicado: (2005)

Prediction of outcome after diagnosis of metachronous contralateral breast cancer
por: Alkner, Sara, et al.
Publicado: (2011)

Contralateral breast dose from partial breast brachytherapy
por: Robinson, R. Cole, et al.
Publicado: (2015)

Adenomyoepithelioma of the Breast in the Setting of Prior Contralateral Breast Malignancy
por: Dauterman, Leah C, et al.
Publicado: (2023)

Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer
por: LI, ZHENG, et al.
Publicado: (2015)

Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
por: Langballe, Rikke, et al.
Publicado: (2016)

The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty
por: Dogan, Lutfi, et al.
Publicado: (2011)

Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
por: van Barele, Mark, et al.
Publicado: (2023)

An overview of prognostic factors for long-term survivors of breast cancer
por: Soerjomataram, Isabelle, et al.
Publicado: (2007)

The impact of coding germline variants on contralateral breast cancer risk and survival
por: Morra, Anna, et al.
Publicado: (2023)

Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands
por: van Breest Smallenburg, V, et al.
Publicado: (2013)

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
por: Verhoog, L C, et al.
Publicado: (2000)

Changes in mammographically normal contralateral breast in cases of breast carcinoma.
por: Prasad, A., et al.
Publicado: (1989)

Patterns of Occurrence and Outcomes of Contralateral Breast Cancer: Analysis of SEER Data
por: Xiong, Zhenchong, et al.
Publicado: (2018)

Mammographic texture features associated with contralateral breast cancer in the WECARE Study
por: Watt, Gordon P., et al.
Publicado: (2021)

Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers
por: de Munck, Linda, et al.
Publicado: (2016)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Rising incidence of breast cancer among female cancer survivors: implications for surveillance
por: Soerjomataram, I, et al.
Publicado: (2009)

The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
por: Nout, R. A., et al.
Publicado: (2007)

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
por: Kriege, M, et al.
Publicado: (2014)

Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal
por: Louwman, W J, et al.
Publicado: (2001)

Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified?
por: de Glas, N. A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gdksfau48d4tpl5jpi75nn70jv